TSM5 (Tesamorelin) 5mg Vial

TSM5 (Tesamorelin) is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), extensively researched for its effects on metabolic regulation, body composition, and cellular aging. Tesamorelin is designed to selectively stimulate GHRH receptors in the anterior pituitary, inducing natural pulsatile growth hormone release and subsequent elevation of IGF-1, which are essential components of the somatotropic axis in metabolic and tissue processes.​

Research Applications
Tesamorelin has been rigorously evaluated in preclinical and clinical research for its capacity to reduce visceral adipose tissue, particularly in models of HIV-associated lipodystrophy and metabolic syndrome. Studies demonstrate significant reductions in central abdominal fat and improvements in the distribution of body composition markers—supporting investigation of lipolytic pathways and adipose tissue remodeling. Experimental data highlight its role in promoting lean muscle preservation, stimulating muscle protein synthesis, and supporting enhanced muscle density.